ZIMMER BIOMET HOLDINGS, INC. Maturities of Senior Debt
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Maturities of Senior Debt of $1.46 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:MaturitiesOfSeniorDebt · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for the quarter ending 2025-12-31 was $600.00M, a 29.41% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for the quarter ending 2025-09-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for the quarter ending 2025-06-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for the quarter ending 2025-03-31 was $863.00M.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for fiscal 2025 was $1.46B, a 72.12% increase from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for fiscal 2024 was $850.00M, a 884.94% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for fiscal 2023 was $86.30M, a 93.24% decline from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. maturities of senior debt for fiscal 2022 was $1.28B.
| Period end | Maturities of Senior Debt 3 month | Maturities of Senior Debt 6 month | Maturities of Senior Debt 9 month | Maturities of Senior Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $600.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $600.00M derived: sum of 2 quarters · filed 2026-02-20 | $600.00M derived: sum of 3 quarters · filed 2026-08-05 | $1.46B 10-K · filed 2026-02-20 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $863.00M 10-Q · filed 2025-11-05 | $1.71B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $863.00M 10-Q · filed 2026-08-05 | $1.71B derived: sum of 3 quarters · filed 2026-08-05 | $1.71B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $863.00M 10-Q · filed 2026-05-01 | $1.71B derived: sum of 2 quarters · filed 2026-05-01 | $1.71B derived: sum of 3 quarters · filed 2026-05-01 | $1.71B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $850.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $850.00M derived: sum of 2 quarters · filed 2026-02-20 | $850.00M derived: sum of 3 quarters · filed 2026-02-20 | $850.00M 10-K · filed 2026-02-20 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $86.30M 10-K · filed 2026-02-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $86.30M 10-Q · filed 2024-10-30 | $612.10M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $86.30M 10-Q · filed 2024-08-07 | $612.10M derived: sum of 3 quarters · filed 2025-02-25 | $612.10M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $86.30M 10-Q · filed 2024-05-02 | $612.10M derived: sum of 2 quarters · filed 2025-02-25 | $612.10M derived: sum of 3 quarters · filed 2025-02-25 | $612.10M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $525.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $525.80M derived: sum of 2 quarters · filed 2025-02-25 | $525.80M derived: sum of 3 quarters · filed 2025-02-25 | $1.28B 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $750.00M 10-Q · filed 2023-11-07 | $2.90B derived: sum of 4 quarters · filed 2024-08-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $750.00M 10-Q · filed 2023-08-01 | $2.90B derived: sum of 3 quarters · filed 2024-08-07 | $3.20B derived: sum of 4 quarters · filed 2024-08-07 |
| 2022-03-31 | $750.00M 10-Q · filed 2023-05-02 | $2.90B derived: sum of 2 quarters · filed 2024-08-07 | $3.20B derived: sum of 3 quarters · filed 2024-08-07 | $3.20B derived: sum of 4 quarters · filed 2024-08-07 |
| 2021-12-31 | $2.15B derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $2.45B derived: sum of 2 quarters · filed 2024-08-07 | $2.45B derived: sum of 3 quarters · filed 2024-08-07 | $2.65B 8-K · filed 2024-08-07 |
| 2021-09-30 | $300.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $300.00M derived: sum of 2 quarters · filed 2022-11-02 | $500.00M 10-Q · filed 2022-11-02 | $750.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $200.00M 10-Q · filed 2022-08-02 | $450.00M derived: sum of 3 quarters · filed 2023-02-24 | $450.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $200.00M 10-Q · filed 2022-05-05 | $450.00M derived: sum of 2 quarters · filed 2023-02-24 | $450.00M derived: sum of 3 quarters · filed 2023-02-24 | |
| 2020-12-31 | $250.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $250.00M derived: sum of 2 quarters · filed 2023-02-24 | $1.75B 10-K · filed 2023-02-24 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.50B 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $1.50B 10-Q · filed 2021-08-03 | |||
| 2019-12-31 | $500.00M 8-K · filed 2022-06-22 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $0.00 derived: sum of 2 quarters · filed 2021-02-22 | $1.15B 10-K · filed 2021-02-22 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.15B 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $1.15B 10-Q · filed 2019-08-05 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-02-21 | $500.00M 10-K · filed 2020-02-21 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $500.00M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $500.00M 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | $1.25B 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $2.76B 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |